Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Butalbital

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Butalbital

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,017Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quagen's Generic Butalbital, Acetaminophen and Caffeine Receives Approval in the U.S.
    Quagen's Generic Butalbital, Acetaminophen and Caffeine Receives Approval in the U.S.

    12 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216376

    FDA
    12 Mar 2024
    Share Share
    Quagen's Generic Butalbital and Acetaminophen Receives Approval in the U.S.
    Quagen's Generic Butalbital and Acetaminophen Receives Approval in the U.S.

    01 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214305

    FDA
    01 Feb 2024
    Share Share
    AACE Pharm's Generic Acetaminophen, Butalbital Receives Approval in the U.S.
    AACE Pharm's Generic Acetaminophen, Butalbital Receives Approval in the U.S.

    16 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214955

    FDA
    16 Aug 2022
    Share Share
    Havix's Generic Acetaminophen Receives Approval in US
    Havix's Generic Acetaminophen Receives Approval in US

    07 Apr 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214088

    FDA
    07 Apr 2022
    Share Share
    Hikma's Generic Dabigatran Etexilate Mesylate Receives Approval in the U.S.
    Hikma's Generic Dabigatran Etexilate Mesylate Receives Approval in the U.S.

    25 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215135

    FDA
    25 Mar 2022
    Share Share
    Seton & Senores Pharma, launch Butalbital, Acetaminophen, Caffeine Capsules
    Seton & Senores Pharma, launch Butalbital, Acetaminophen, Caffeine Capsules

    17 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/seton-pharmaceuticals-llc-and-senores-pharmaceuticals-inc-launch-butalbital-acetaminophen-and-caffeine-capsules-usp-50-mg325-mg40-mg-in-the-us-market-301505001.html

    PRNEWSWIRE
    17 Mar 2022
    Share Share